{"resourceType":"Bundle","type":"searchset","entry":[{"resource":{"resourceType":"Parameters","id":"ImmDS-2013-0193","parameter":[{"name":"assessentDate","valueDate":"2020-06-29"},{"name":"patient","resource":{"resourceType":"Patient","id":"2013-0193","name":[{"text":"Dose 1 to Dose 2 interval 6 mo-4 days.  Series complete.\nEvaluation_Test_Type: Interval: At Absolute Minimum\nGeneral_Description: This test case describes when the second dose of the HepA 2 dose vaccine is administered at 6 months - 4 days, that the dose is considered valid and the series is considered complete."}],"gender":"female","birthDate":"2016-01-03"}},{"name":"immunization","resource":{"resourceType":"Immunization","id":"2013-0193-dose1","status":"completed","date":"2020-01-03T00:00:00.000","vaccineCode":{"coding":[{"system":"http://hl7.org/fhir/sid/cvx","code":"85","display":"Hep A, unspecified formulation"}]},"patient":{"reference":"Patient/2013-0193"},"wasNotGiven":false,"reported":false}},{"name":"immunization","resource":{"resourceType":"Immunization","id":"2013-0193-dose2","status":"completed","date":"2020-06-29T00:00:00.000","vaccineCode":{"coding":[{"system":"http://hl7.org/fhir/sid/cvx","code":"85","display":"Hep A, unspecified formulation"}]},"patient":{"reference":"Patient/2013-0193"},"wasNotGiven":false,"reported":false}}]},"request":{"method":"PUT","url":"Parameters"}},{"resource":{"resourceType":"Parameters","parameter":[{"name":"recommendation","resource":{"resourceType":"ImmunizationRecommendation","patient":{"reference":"Patient/2013-0193"},"recommendation":[{"date":"2020-06-29T00:00:00.000","vaccineCode":{"coding":[{"system":"http://hl7.org/fhir/sid/cvx","display":"HepA"}]},"forecastStatus":{"coding":[{"system":"http://hl7.org/fhir/us/ImmunizationFHIRDS/CodeSystem/ForecastStatus","code":"complete","display":"Complete"}]},"dateCriterion":[{"code":{"coding":[{"system":"http://loinc.org","code":"30981-5","display":"Earliest date to give"}]},"value":"2999-12-31T00:00:00.000"},{"code":{"coding":[{"system":"http://loinc.org","code":"30980-7","display":"Date vaccine due"}]},"value":"2999-12-31T00:00:00.000"},{"code":{"coding":[{"system":"http://loinc.org","code":"59778-1","display":"Date when overdue for immunization"}]},"value":"2999-12-31T00:00:00.000"}],"protocol":{"description":"Evaluation_Test_Type: Interval: At Absolute Minimum\nForecast_Test_Type: EvaluationNot recommended: series complete\nGeneral_Description: This test case describes when the second dose of the HepA 2 dose vaccine is administered at 6 months - 4 days, that the dose is considered valid and the series is considered complete.","series":"HepA"}}]}}]},"request":{"method":"PUT","url":"Parameters"}}]}